MorphoSys AG, a German biotechnology company, and industrial enzyme manufacturer Novozymes signed a licensing agreement for MorphoSys’ patented Slonomics technology. Using Slonomics as an automated enzyme engineering tool will allow Novozymes’ researchers to reduce the time needed to develop new enzymes. “In order to develop the best enzymes in the most efficient way we need access to the best available technologies," says Ejner Bech Jensen, Vice President of Novozymes Research & Development. Read more ...
No comments:
Post a Comment